Conjunctivitis secondary prevention: Difference between revisions
No edit summary |
No edit summary |
||
| Line 10: | Line 10: | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
===Infective Conjunctivitis=== | ===Infective Conjunctivitis=== | ||
Effective | Effective measure for the secondary prevention of infective conjunctivitis include:<ref name="pmid17696792">{{cite journal| author=Rose P| title=Management strategies for acute infective conjunctivitis in primary care: a systematic review. | journal=Expert Opin Pharmacother | year= 2007 | volume= 8 | issue= 12 | pages= 1903-21 | pmid=17696792 | doi=10.1517/14656566.8.12.1903 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17696792 }} </ref> | ||
* Discontinued [[contact lens]] wear ('''infective Conjunctivitis''') | * Discontinued [[contact lens]] wear ('''infective Conjunctivitis''') | ||
===Neonatal Conjunctivitis=== | ===Neonatal Conjunctivitis=== | ||
Revision as of 18:49, 7 July 2016
|
Conjunctivitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Conjunctivitis secondary prevention On the Web |
|
American Roentgen Ray Society Images of Conjunctivitis secondary prevention |
|
Risk calculators and risk factors for Conjunctivitis secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]
Overview
Secondary prevention strategies following conjunctivitis include ocular prophylaxis with 0.5% erythromycin ointment or 1% tetracycline hydrochloride (all newborns), discontinued contact lens wear (infective conjunctivitis), identify the allergen and avoid the antigen (allergic conjunctivitis). Secondary prevention strategies following keratoconjunctivitis sicca (dry eye syndrome) include avoid very dry environments, dusty and smoky areas and prolonged visual tasks. There is no established method for secondary prevention of superior limbic Keratoconjunctivitis. However, educating patients about disease process can improve compliance of patients with treatment, and help them to cope with the often prolonged symptoms.[1][2][3][4][5]
Secondary Prevention
Infective Conjunctivitis
Effective measure for the secondary prevention of infective conjunctivitis include:[1]
- Discontinued contact lens wear (infective Conjunctivitis)
Neonatal Conjunctivitis
Effective measures for the secondary prevention of neonatal conjunctivitis include:[2]
- Ocular prophylaxis with 0.5% erythromycin ointment or 1% tetracycline hydrochloride be given to all newborns.
Allergic conjunctivitis
Effective measures for the secondary prevention of allergic conjunctivitis include:[3]
- Identify the allergen and avoid the offending antigen
- Discontinued contact lens wear
Keratoconjunctivitis Sicca
Effective measures for the secondary prevention of keratoconjunctivitis sicca (dry eye syndrome) include:[4]
- Avoid very dry environments (Furnaces and air conditioning can dry the air)
- Use a humidifier (puts moisture back into the air to prevent dry eyes)
- Avoid dusty and smoky areas
- Avoid prolonged visual tasks (staring at a computer screen, driving, watching television, and reading)
- Promptly use artificial tears
Superior Limbic Keratoconjunctivitis
There is no established method for secondary prevention of superior limbic Keratoconjunctivitis. However, educating patients about disease process can improve compliance of patients with treatment, and help them to cope with the often prolonged symptoms.[5]
References
- ↑ 1.0 1.1 Rose P (2007). "Management strategies for acute infective conjunctivitis in primary care: a systematic review". Expert Opin Pharmacother. 8 (12): 1903–21. doi:10.1517/14656566.8.12.1903. PMID 17696792.
- ↑ 2.0 2.1 Matejcek A, Goldman RD (2013). "Treatment and prevention of ophthalmia neonatorum". Can Fam Physician. 59 (11): 1187–90. PMC 3828094. PMID 24235191.
- ↑ 3.0 3.1 La Rosa M, Lionetti E, Reibaldi M, Russo A, Longo A, Leonardi S; et al. (2013). "Allergic conjunctivitis: a comprehensive review of the literature". Ital J Pediatr. 39: 18. doi:10.1186/1824-7288-39-18. PMC 3640929. PMID 23497516.
- ↑ 4.0 4.1 Messmer EM (2015). "The pathophysiology, diagnosis, and treatment of dry eye disease". Dtsch Arztebl Int. 112 (5): 71–81, quiz 82. doi:10.3238/arztebl.2015.0071. PMC 4335585. PMID 25686388.
- ↑ 5.0 5.1 Nelson JD (1989). "Superior limbic keratoconjunctivitis (SLK)". Eye (Lond). 3 ( Pt 2): 180–9. doi:10.1038/eye.1989.26. PMID 2695351.